Raloxifene Hydrochloride
- Product NDC
- 71335-1663
- 11-digit product format
- 713351663
- Labeler code
- 71335
- Product ID
- 71335-1663_ac4f5eb7-441c-4b01-bbce-71d5c118bfa0
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Raloxifene
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA090842
- Marketing category
- ANDA
- Marketing start
- 2016-06-29
- Marketing end
- 0000-00-00
- Substance
- RALOXIFENE HYDROCHLORIDE
- Active strength
- 60 mg/1
- Pharmacologic classes
- Estrogen Agonist/Antagonist [EPC], Selective Estrogen Receptor Modulators [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 71335-1663 | I | Inactivated by FDA | 2026-07-31 | ||
| excluded package | package | 71335-1663 | 71335-1663-1 | I | Inactivated by FDA | 2026-07-31 | |
| excluded package | package | 71335-1663 | 71335-1663-2 | I | Inactivated by FDA | 2026-07-31 |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A090842-001 | RALOXIFENE HYDROCHLORIDE | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2014-09-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A090842-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090842-001 | RALOXIFENE HYDROCHLORIDE | 60MG | TABLET / ORAL | AB | 2014-09-24 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A090842-001 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Raloxifene Hydrochloride | RALOXIFENE | American Health Packaging | f5c25553-1546-451d-8069-c0f484c47741 | 2024-05-13 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 |
| Raloxifene Hydrochloride | RALOXIFENE | Aphena Pharma Solutions - Tennessee, LLC | 53a2db10-4af8-4032-b598-b7c7a0969801 | 2021-03-17 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 |
| Raloxifene Hydrochloride | RALOXIFENE HYDROCHLORIDE | Exelan Pharmaceuticals, Inc. | 2b94ecf5-d870-4132-b455-d5ee5c9dce56 | 2020-09-30 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 |
| Raloxifene Hydrochloride | RALOXIFENE | Cipla USA Inc. | 8fef5bfd-a786-4442-b09b-f3b81812cdac | 2020-09-07 | Boxed warning, Warnings, Adverse reactions | 090842 ANDA090842 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 7ad62b49-6132-2a8c-4edd-73f39b2bf45c | Product name | 6 | 20210312 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-1663-1 | Raloxifene Hydrochloride | 60 in 1 BOTTLE | TABLET | 60 | 2 | |
| 71335-1663-2 | Raloxifene Hydrochloride | 30 in 1 BOTTLE | TABLET | 30 | 2 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 71335-1663 | RALOXIFENE HYDROCHLORIDE (RALOXIFENE) TABLET [BRYANT RANCH PREPACK] | 2 | Legacy NDC, 2 package rows | 20221202_ae557c81-e206-47fd-881e-b8f7fca2a3b0.zip |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1490065 | raloxifene HCl 60 MG Oral Tablet | PSN | ae557c81-e206-47fd-881e-b8f7fca2a3b0 | 2 |
| 1490065 | raloxifene hydrochloride 60 MG Oral Tablet | SCD | ae557c81-e206-47fd-881e-b8f7fca2a3b0 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71335-1663-1 | 71335166301 | 60 TABLET in 1 BOTTLE (71335-1663-1) | 60 tablet | 2020-07-15 | 0000-00-00 | No | No | Current |
| 71335-1663-2 | 71335166302 | 30 TABLET in 1 BOTTLE (71335-1663-2) | 30 tablet | 2020-07-15 | 0000-00-00 | No | No | Current |